FDA Compliance for Peptide Therapy and BPC 157 Holt Law The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence